| John B Wahlig, MD | |
|
195 Fore River Pkwy, Suite 490, Portland, ME 04102-2780 | |
| (207) 553-6054 | |
| (207) 553-6076 |
| Full Name | John B Wahlig |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 30 Years |
| Location | 195 Fore River Pkwy, Portland, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790729051 | NPI | - | NPPES |
| 30204407 | Medicaid | NH | |
| 410600099 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD16536 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northern Light Home Care & Hospice | So portland, ME | Home health agency |
| Northern Light Mercy Hospital | Portland, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Hospital | 6103737812 | 207 |
News Archive
To get to the top is difficult; to stay at the top is even more difficult. Every athlete knows that and this also applies to the trade show business.
Researchers have developed a risk assessment scoring system that they believe may better identify certain adults- especially African Americans- at high risk of developing type 2 diabetes, heart disease and stroke than does the current system of diagnosing the metabolic syndrome.
Ignyta, Inc., an oncology precision medicine biotechnology company, announced today that Justin Gainor, M.D., of the Massachusetts General Hospital Cancer Center, presented preliminary results from the ongoing Phase 1 dose escalation portion of a Phase 1/2 clinical trial of RXDX-101, Ignyta's proprietary oral tyrosine kinase inhibitor targeting solid tumor indications, at the International Association for the Study of Lung Cancer 14th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
Boston Scientific Corporation today announced Health Canada approval of the Blazer Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias.
Combined Insurance, a leading provider of individual supplemental accident, disability, health and life insurance products, and a Chubb company, is encouraging consumers to educate themselves about the value of life insurance during Life Insurance Awareness Month.
› Verified 9 days ago
| Entity Name | Mercy Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629078712 PECOS PAC ID: 6103737812 Enrollment ID: O20040217000943 |
News Archive
To get to the top is difficult; to stay at the top is even more difficult. Every athlete knows that and this also applies to the trade show business.
Researchers have developed a risk assessment scoring system that they believe may better identify certain adults- especially African Americans- at high risk of developing type 2 diabetes, heart disease and stroke than does the current system of diagnosing the metabolic syndrome.
Ignyta, Inc., an oncology precision medicine biotechnology company, announced today that Justin Gainor, M.D., of the Massachusetts General Hospital Cancer Center, presented preliminary results from the ongoing Phase 1 dose escalation portion of a Phase 1/2 clinical trial of RXDX-101, Ignyta's proprietary oral tyrosine kinase inhibitor targeting solid tumor indications, at the International Association for the Study of Lung Cancer 14th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
Boston Scientific Corporation today announced Health Canada approval of the Blazer Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias.
Combined Insurance, a leading provider of individual supplemental accident, disability, health and life insurance products, and a Chubb company, is encouraging consumers to educate themselves about the value of life insurance during Life Insurance Awareness Month.
› Verified 9 days ago
| Entity Name | Eastern Maine Healthcare Systems Inland Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376579557 PECOS PAC ID: 6305817503 Enrollment ID: O20040802001656 |
News Archive
To get to the top is difficult; to stay at the top is even more difficult. Every athlete knows that and this also applies to the trade show business.
Researchers have developed a risk assessment scoring system that they believe may better identify certain adults- especially African Americans- at high risk of developing type 2 diabetes, heart disease and stroke than does the current system of diagnosing the metabolic syndrome.
Ignyta, Inc., an oncology precision medicine biotechnology company, announced today that Justin Gainor, M.D., of the Massachusetts General Hospital Cancer Center, presented preliminary results from the ongoing Phase 1 dose escalation portion of a Phase 1/2 clinical trial of RXDX-101, Ignyta's proprietary oral tyrosine kinase inhibitor targeting solid tumor indications, at the International Association for the Study of Lung Cancer 14th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
Boston Scientific Corporation today announced Health Canada approval of the Blazer Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias.
Combined Insurance, a leading provider of individual supplemental accident, disability, health and life insurance products, and a Chubb company, is encouraging consumers to educate themselves about the value of life insurance during Life Insurance Awareness Month.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John B Wahlig, MD 195 Fore River Pkwy, Suite 490, Portland, ME 04102-2780 Ph: (207) 553-6054 | John B Wahlig, MD 195 Fore River Pkwy, Suite 490, Portland, ME 04102-2780 Ph: (207) 553-6054 |
News Archive
To get to the top is difficult; to stay at the top is even more difficult. Every athlete knows that and this also applies to the trade show business.
Researchers have developed a risk assessment scoring system that they believe may better identify certain adults- especially African Americans- at high risk of developing type 2 diabetes, heart disease and stroke than does the current system of diagnosing the metabolic syndrome.
Ignyta, Inc., an oncology precision medicine biotechnology company, announced today that Justin Gainor, M.D., of the Massachusetts General Hospital Cancer Center, presented preliminary results from the ongoing Phase 1 dose escalation portion of a Phase 1/2 clinical trial of RXDX-101, Ignyta's proprietary oral tyrosine kinase inhibitor targeting solid tumor indications, at the International Association for the Study of Lung Cancer 14th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
Boston Scientific Corporation today announced Health Canada approval of the Blazer Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias.
Combined Insurance, a leading provider of individual supplemental accident, disability, health and life insurance products, and a Chubb company, is encouraging consumers to educate themselves about the value of life insurance during Life Insurance Awareness Month.
› Verified 9 days ago
Lee L. Thibodeau, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 195 Fore River Pkwy, Suite 490, Portland, ME 04102 Phone: 207-553-6054 Fax: 207-553-6076 | |
Nicolas Flannery Arredondo, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 195 Fore River Pkwy Ste 440, Portland, ME 04102 Phone: 207-553-6054 Fax: 207-553-6076 |